Talecris Biotherapeutics Inc.

The US Federal Trade Commission’s legal challenge to block Amgen, Inc. ’s proposed acquisition of Horizon Therapeutics plc was resolved with the agency formalizing Amgen’s commitment not to bundle

The US Federal Trade Commission signaled its intent to pursue novel theories of anticompetitive harm in reviewing biopharmaceutical transactions two years ago. It finally did so in filing a lawsuit to

The German majority owner of CureVac AG has declared his commitment to making the company’s potential coronavirus vaccine available to people globally, from Germany. His comments come after Donald T

The biotech boom of the past several years saw record-breaking IPO volume across the entire sector. Central nervous system (CNS) therapeutics companies received their fair share of attention, particul